Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.1016/j.bbi.2020.05.022
dc.identifier.other
dc.description.volume
87
dc.description.issue
JUL
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI
10.1016/j.bbi.2020.05.022
Abstract
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).